NEWS

Thursday, February 4, 2021

Vårt mål er at nye kreftbehandlinger i samarbeid skal utvikles på 5 istedenfor 10 år.

Tuesday, February 2, 2021

Hemispherian closed successful seed financing round

Friday, January 29, 2021

Roche contributes eight cancer medicines to IMPRESS-Norway.

Tuesday, January 19, 2021

Our school collaboration project has opened unexpected doors for Eivind.

Friday, January 15, 2021

Norwegian government to double the number of clinical studies.

Thursday, January 14, 2021

Dehns acquires Norwegian Intellectual Property consultancy Leogriff.

Tuesday, January 12, 2021

Ultimovacs has announced a new clinical study targeted at patients with ovarian cancer.

Monday, December 21, 2020

CONNECT is a completely new public-private collaboration in cancer precision medicine.

Friday, December 18, 2020

Read a selection of our news from 2020.